Organization | Vabiotech

Vabiotech Report issue

Government Phase 4

Founded: Hanoi Vietnam (2007)

Organization Overview

First Clinical Trial

2018

NCT03931239

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Vabiotech

Active Ingredients

Drugs in Phase 4 Trials (1)

varicella-zoster virus strain oka/live (1 trial)

Drugs in Other Trials (2)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)

hybrid 5 component dtap, vero ipv, hep b and prp-ompc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chickenpox (Phase 4)

Herpes Zoster (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 3